Key insights
- T3 Defense has completed a significant sale of over 15 million shares to Esousa Group Holdings, raising approximately $3.8 million. This capital injection comes as the company faces severe financial distress, evidenced by a weak financial health score and rapid cash burn. While the transaction provides immediate liquidity, the stock's dramatic year-long decline and ongoing financial pressures suggest continued headwinds for the company, potentially signaling broader investor caution in similar distressed situations.
T3 Defense Inc. (NASDAQ:DFNS) reported Monday that it has sold 15,187,265 shares of common stock to Esousa Group Holdings, LLC, generating $3,805,929 in gross proceeds. The sale was conducted under a common stock purchase agreement dated September 19, 2025, and was made pursuant to a registration statement declared effective by the Securities and Exchange Commission on December 23, 2025. The capital raise comes as the company faces financial pressures, with a current ratio of just 0.25 and an overall financial health score rated as "WEAK" by InvestingPro analysis.
According to a company press release, this transaction was completed on June 12. In connection with the sale, Esousa Group Holdings waived a prohibition against T3 Defense issuing purchase notices under an existing equity line program, as outlined in a securities purchase agreement dated February 24, 2026.
The company also detailed additional share purchases by Esousa Group Holdings in recent months. On April 20, 2026, 74,880 shares were purchased for $42,232. On May 15, 146,706 shares were purchased for $61,925, followed by 284,236 shares for $96,299 on May 22. On May 29, 1,237,361 shares were purchased for $425,652, and on June 4, 364,336 shares were purchased for $113,199.
The aggregate total for all these transactions, including the June 12 sale, is 17,294,784 shares sold for $4,545,236 in gross proceeds. The stock, currently trading at $0.21, has declined 29.9% over the past week and nearly 99% over the past year. InvestingPro Tips highlight that the company is "quickly burning through cash," with 16 additional tips available to subscribers.
T3 Defense stated that there is no assurance of future waivers by Esousa Group Holdings regarding the equity line program, and that further sales may be subject to conditions in the February 24, 2026, securities purchase agreement.
As of Monday, T3 Defense reported 94,832,476 common shares and 200 shares of Series B Convertible Preferred Stock issued and outstanding.
The company’s common stock and warrants are listed on the Nasdaq Stock Market under the symbols DFNS and DFNSW, respectively. This information is based on a press release statement included in a recent SEC filing.
In other recent news, T3 Defense Inc. reported preliminary first-quarter revenue of approximately $4.2 million and reaffirmed its full-year revenue guidance of $26 million. The company also noted a backlog of $12.1 million across its subsidiaries as of the end of March 2026. Additionally, T3 Defense announced the completion of the sale of its subsidiary ZorroNet to BiomX Inc., involving a mix of stock and cash. In another development, T3 Defense’s subsidiary, Rimon Agencies Ltd., delivered a mobile interceptor system platform to Elbit Group’s IMI Systems. Furthermore, T3 Defense disclosed that Water IO Ltd., a majority-owned subsidiary, signed a non-binding letter of intent to lend $10 million to Meteor Aerospace Ltd., potentially granting Water IO a 51% stake in Meteor Aerospace. The company also announced the appointment of Roy Cohen as its new chief financial officer, effective June 1. These developments indicate ongoing strategic and financial activities within T3 Defense Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy.Get the bottom line for PHGE plus thousands of other stocks and find your next hidden gem with massive upside.